30 Day FDA and ICH Drug Development Regulations - Day 27 Regulatory Submissions

Explore the fascinating and often hidden world of regulatory submissions, the backbone of bringing new drugs from lab to market. This episode unpacks the journey from investigational new drug applications (INDs) to new drug applications (NDAs) and biologics license applications (BLAs), revealing the intricate processes that ensure safety, efficacy, and quality. Learn about the key elements of these submissions, including clinical trial designs, manufacturing standards, and even the packaging and labeling that protect patients. Gain insight into the global collaboration behind modern medicine, where science, regulation, and innovation intersect to shape the future of healthcare.